GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.268
-0.015 (-5.16%)
Apr 29, 2026, 11:24 AM EDT - Market open
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $8.47 million as of April 29, 2026. Its market cap has increased by 69.32% in one year.
Market Cap
8.47M
Enterprise Value
2.12M
1-Year Change
69.32%
Ranking
Category
Stock Price
$0.27
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $8.47M, a decrease of -89.82%. That is a compound annual growth rate of -24.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 8.90M | 7.23% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quoin Pharmaceuticals | 9.85M |
| Evogene | 9.67M |
| Bolt Biotherapeutics | 9.53M |
| CalciMedica | 9.29M |
| NuCana | 9.20M |
| Liminatus Pharma | 9.09M |
| Genprex | 8.56M |
| Creative Medical Technology Holdings | 8.43M |